NEUROCRINE BIOSCIENCES INC

NBIX Mostly scheduled

CIK 0000914475 #761 in the set updated 17 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$77.87M

$2.32M on a plan · $75.51M straight out of an exercise

Sold at will

$42.59K

1 of 40 sales

Net

−$77.87M

−$42.59K against sales at will

By person

20 insiders · 42 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

GORMAN KEVIN CHARLES

Director

—

$37.82M (1) scheduled

−$37.82M

517,797

0.5094%

$81.40M

+0.6%

Cooke Julie

Chief Human Resources Officer

—

$5.77M (5) scheduled

−$5.77M

24,025

0.0236%

$3.78M

+29.3%

Gano Kyle

Chief Executive Officer

—

$4.87M (3) scheduled

−$4.87M

154,728

0.1522%

$24.32M

+14.0%

Lippoldt Darin

Chief Legal Officer

—

$4.20M (5) scheduled

−$4.20M

56,793

0.0559%

$8.93M

+42.9%

SHERWIN STEPHEN A

Director

—

$4.13M (5) scheduled

−$4.13M

14,860

0.0146%

$2.34M

−43.9%

Delaet Ingrid

Chief Regulatory Officer

—

$3.75M (5) scheduled

−$3.75M

18,289

0.0180%

$2.87M

+629.5%

Onyia Jude

Chief Scientific Officer

—

$3.47M (2) scheduled

−$3.47M

22,647

0.0223%

$3.56M

+64.9%

RASTETTER WILLIAM H

Director

—

$2.73M (1) scheduled

−$2.73M

43,678

0.0430%

$6.87M

+16.5%

POPS RICHARD F

Director

—

$2.36M (1) scheduled

−$2.36M

37,798

0.0372%

$5.94M

+19.6%

LYONS GARY A

Director

—

$2.29M (1) scheduled

−$2.29M

122,141

0.1202%

$19.20M

+2.6%

MORROW GEORGE J

Director

—

$2.15M (1) scheduled

−$2.15M

10,386

0.0102%

$1.63M

+147.3%

Norwalk Leslie V

Director

—

$1.97M (5) scheduled

−$1.97M

2,430

0.0024%

$381.99K

+144.5%

BENEVICH ERIC

Chief Commercial Officer

—

$1.24M (2) scheduled

−$1.24M

67,297

0.0662%

$10.58M

+40.0%

Boyer David W.

Chief Corp. Affairs Officer

—

$739.07K (2) scheduled

−$739.07K

8,722

0.0086%

$1.37M

+312.0%

ABERNETHY MATT

Chief Financial Officer

—

$363.28K (1) scheduled

−$363.28K

42,808

0.0421%

$6.73M

+34.1%

ROBERTS EIRY

Chief Medical Officer

—

—

—

35,640

0.0351%

$5.60M

+50.3%

Mercier Johanna

Director

—

—

—

6,853

0.0067%

$1.08M

+226.3%

POON CHRISTINE A

Director

—

—

—

4,753

0.0047%

$747.16K

—

Sharp Shalini

Director

—

—

—

4,088

0.0040%

$642.63K

+311.3%

Keswani Sanjay Chandru

Chief Medical Officer

—

—

—

3,281

0.0032%

$515.77K

—

Individual transactions

2

Insider

Date

Role

Action

Shares

Price

Amount

Norwalk Leslie V

29 Jul 2026

Director

Exercised, kept

842

$139.43

$117.40K

Lippoldt Darin

8 Jan 2026

Chief Legal Officer

Exercised, kept

3,349

$35.99

$120.53K

Show all 42 transactions →

What was left out

Form 4 filings counted 80

Amendments (4/A) skipped 1

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 7

Sales straight out of an exercise 32

Sales at will 1

Transactions with no price 0

Shares from compensation/vesting 969,824

History held since 2 Sep 2016